148 related articles for article (PubMed ID: 25283278)
1. Comparison of LUMIPULSE(®) G1200 With Kryptor and Modular E170 for the Measurement of Seven Tumor Markers.
Marlet J; Bernard M
J Clin Lab Anal; 2016 Jan; 30(1):5-12. PubMed ID: 25283278
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000.
de Rancher MR; Oudart JB; Maquart FX; Monboisse JC; Ramont L
Clin Biochem; 2016 Nov; 49(16-17):1302-1306. PubMed ID: 27521619
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System.
Oh J; Kim JH; Park HD
Ann Lab Med; 2018 Nov; 38(6):530-537. PubMed ID: 30027696
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers.
Falzarano R; Viggiani V; Michienzi S; Longo F; Tudini S; Frati L; Anastasi E
Tumour Biol; 2013 Oct; 34(5):3093-100. PubMed ID: 23775009
[TBL] [Abstract][Full Text] [Related]
5. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay.
Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP
Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone.
Lotierzo M; Urbain V; Dupuy AM; Cristol JP
Pract Lab Med; 2021 May; 25():e00220. PubMed ID: 34095410
[TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of LUMIPULSE G1200 autoimmunoanalyzer for the detection of serum hepatitis B virus markers.
Choi SJ; Park Y; Lee EY; Kim S; Kim HS
J Clin Lab Anal; 2013 May; 27(3):204-6. PubMed ID: 23440745
[TBL] [Abstract][Full Text] [Related]
8. Imprecision of tumour biomarker measurements on Roche Modular E170 platform fulfills desirable goals derived from biological variation.
Dolci A; Scapellato L; Mozzi R; Panteghini M
Ann Clin Biochem; 2010 Mar; 47(Pt 2):171-3. PubMed ID: 20144978
[TBL] [Abstract][Full Text] [Related]
9. Analytical Evaluation of Lumipulse Anti-Mullerian Hormone Assay.
Fraissinet F; Gesland A; Guillerme J; Ziegler F; Brunel V
Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107635
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
Ryu MR; Kang ES; Park HD
J Clin Lab Anal; 2019 Jul; 33(6):e22921. PubMed ID: 31131509
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest.
Dakterzada F; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Piñol-Ripoll G
Front Aging Neurosci; 2021; 13():604119. PubMed ID: 33746733
[TBL] [Abstract][Full Text] [Related]
12. Verification of the harmonization of human epididymis protein 4 assays.
Ferraro S; Borille S; Carnevale A; Frusciante E; Bassani N; Panteghini M
Clin Chem Lab Med; 2016 Oct; 54(10):1635-43. PubMed ID: 27028735
[TBL] [Abstract][Full Text] [Related]
13. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
14. Automated measurement of 25-OH Vitamin D on the LUMIPULSE
Parra M; Foj L; Filella X
Br J Biomed Sci; 2016 Jul; 73(3):104-109. PubMed ID: 27310165
[TBL] [Abstract][Full Text] [Related]
15. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay.
Hermsen D; Apple F; Garcia-Beltràn L; Jaffe A; Karon B; Lewandrowski E; Mühlbacher A; Müller R; Ordóñez J; Pagani F; Panteghini M; Plecko T; Jarausch J
Clin Lab; 2007; 53(1-2):1-9. PubMed ID: 17323819
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Four Automated Carcinoembryonic Antigen Immunoassays: ADVIA Centaur XP, ARCHITECT I2000sr, Elecsys E170, and Unicel Dxi800.
Park J; Lee S; Kim Y; Choi A; Lee H; Lim J; Kim Y; Han K; Oh EJ
Ann Lab Med; 2018 Jul; 38(4):355-361. PubMed ID: 29611386
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the test methods (KRYPTOR, ES 600 and CIS-RIA) for CEA, CA 15-3 and CA 125 follow-up and ONCOCHECK-quality control.
Bauer T; Charl S; Sturm G
Anticancer Res; 2000; 20(6D):5245-7. PubMed ID: 11326703
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the UniCel™ DxI 800 immunoassay analyzer in measuring five tumor markers.
Park Y; Park Y; Park J; Kim HS
Yonsei Med J; 2012 May; 53(3):557-64. PubMed ID: 22477000
[TBL] [Abstract][Full Text] [Related]
19. Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ
Bayart JL; Hanseeuw B; Ivanoiu A; van Pesch V
J Neurol; 2019 Sep; 266(9):2304-2311. PubMed ID: 31179518
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patients.
van Halewijn GJ; Geurtsvankessel CH; Klaasse J; van Oord GW; de Knegt RJ; van Campenhout MJ; Boonstra A; van der Eijk AA
J Clin Virol; 2019 May; 114():1-5. PubMed ID: 30852396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
